Skip to content
Advertisement

Tanja Erichsen, from the Danish Medicines Agency speaks during a press briefing about the status of the AstraZeneca COVID-19 vaccine , n Copenhagen, Thursday, March 25, 2021. Danish officials have decided to extend their suspension of the AstraZeneca COVID-19 vaccine by three weeks while they continue evaluating the vaccine’s potential link with blood clots. Denmark first paused the use of the AstraZeneca vaccine as a precautionary measure on March 11. (Mads Claus Rasmussen/Ritzau Scanpix via AP)

Tanja Erichsen, from the Danish Medicines Agency speaks during a press briefing about the status of the AstraZeneca COVID-19 vaccine , n Copenhagen, Thursday, March 25, 2021. Danish officials have decided to extend their suspension of the AstraZeneca COVID-19 vaccine by three weeks while they continue evaluating the vaccine’s potential link with blood clots. Denmark first paused the use of the AstraZeneca vaccine as a precautionary measure on March 11. (Mads Claus Rasmussen/Ritzau Scanpix via AP)

Featured Photo Galleries